Valuation check: CDNA's profit margin is 24.23%, above the Healthcare sector average of 13.89%.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
The latest profit margin for CDNA is 24.23% as of June 2026. That compares with 15.16% in the prior-year period — up 59.8% year over year. That is above the Healthcare sector average of 13.89%. Investors often review this figure alongside Caredx's historical trend and sector peers before judging valuation or financial health.
Over the past year, CDNA's profit margin moved from 15.16% to 24.23% — a 59.8% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Caredx's valuation or profitability profile.
Against Healthcare companies, CDNA currently prints 24.23% for profit margin, while the sector average sits near 13.89%. That is roughly 74.5% above the sector mean. Large gaps often invite a closer look at Caredx's growth, margins, and balance sheet.
Profit Margin shows how effectively Caredx converts resources into returns. At 24.23%, CDNA may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 15.16% in the prior-year period — up 59.8% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting CDNA's profit margin (24.23%), review year-over-year change from 15.16%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.